Newswise — Falls Church, Virginia. Sep. 20, 2012—The American Thyroid Association (ATA) today at its 82 Annual Meeting in Québec City, Québec, Canada named Hossein Gharib, MD, as President-elect, Gregory Randolph, MD, as Treasurer-elect, and Susan Sherman, MD, and James Hennessey, MD, as members of its Board of Directors. Current President-elect Bryan Haugen, MD, assumed the position of President of the ATA.
Dr. Bryan Haugen is Professor of Medicine and Pathology at the University of Colorado Denver and Chief of the Division of Endocrinology, Metabolism & Diabetes. He received a Bachelor’s degree in Chemistry from St. Olaf College and completed his medical degree at the Mayo Medical School. He pursued an internal medicine residency and endocrinology clinical/research fellowship at the University of Colorado.
Dr. Haugen has been a member of the ATA since 1994. He has served on the Program Committee, Clinical Affairs Committee and Nominating Committee. He served as a member of the local organizing committee for the 1998 Annual meeting and Program co-chair for the 2003 Annual Meeting. He has also served on the Board of Directors (2003-2007). He has been a member of the thyroid nodules and cancer task force that developed the 2006 and 2009 guidelines. He has been on the editorial board of Thyroid since 1998 and an Associate Editor since 2008.
Dr. Haugen has served on editorial boards of Thyroid, Journal of Clinical Endocrinology and Metabolism, and Endocrinology. He has been an active member of the National Thyroid Cancer Treatment Cooperative Study Group. He has also served on study sections for the NIH and various cancer organizations. Dr. Haugen has been elected as a Fellow in the American College of Physicians and he has received the Boots Clinical Thyroid Fellowship (1993) as well as the Abbott Thyroid Clinical Research Mentor (2008) Awards from the Endocrine Society.
“I have greatly benefited from the training and mentorship of many leaders within the ATA,” says Dr. Haugen. “Together, we can continue that honored tradition to advocate for thyroid health, understand thyroid biology and disease and train the next generation of thyroidologists to carry on the important mission of the ATA.”
Incoming President-elect Dr. Gharib is Professor of Medicine in the Division of Endocrinology, Diabetes, Metabolism, and Nutrition at the Mayo Clinic. He received his undergraduate education at the Ohio State University, his medical education at the University of Michigan, and completed his internal medicine residency & endocrine training at Mayo.
A member of the ATA since 1972, Dr. Gharib has served as a member of the Patient Education and Advocacy, Membership, Education, and Development Committees. He is currently an Editorial Board member of the Thyroid. He has regularly attended and presented posters or talks at the ATA annual scientific meetings. He served on the Task Forces that developed the Medullary Thyroid Cancer Guidelines in 2010 and the Hypothyroidism Guidelines in 2012. In 2002, he was honored with the prestigious Paul Starr Award.
Dr. Gharib has lectured at over 250 national and international endocrine meetings. He has authored or coauthored more than 250 academic papers, including peer-reviewed journal articles, guidelines for medical practice, scientific meeting abstracts, reviews and book chapters. He has served on the editorial boards of JCEM, Endocrine Practice, Acta Endocrinologia (Romania), International Journal of Endocrinology & Metabolism, and Endocrinology.
“I am proud to be part of this great organization, and grateful and humbled by the opportunity to serve you as its next President-elect. I remain confident and optimistic about our future,” said Dr. Gharib.
Dr. Randolph, named ATA Treasurer-elect by acclamation, is an Associate Professor of Otolaryngology Head and Neck Surgery at Harvard Medical School and Surgeon at Massachusetts Eye & Ear Infirmary. He trained
at Cornell and Harvard Medical Schools.
He has served as the Director of the General Otolaryngology Division since 1995. He founded and directs the Division of Thyroid and Parathyroid Surgery of Massachusetts Eye & Ear Infirmary and serves on the Endocrine Surgical Service at Massachusetts General Hospital in the Division of Surgical Oncology. He serves on the Board of Directors for the American Academy of Otolaryngology Head and Neck Surgery.
Dr. Randolph is currently Chair of the ATA Development Committee and the thyroid cancer nodal micrometastasis subgroup. He has served as a member of the ATA Surgical Advisory Committee and the ATA Central Neck Dissection guideline advisory group. In addition, he is a member of the Thyroid editorial board.
Dr. Hennessey, newly appointed to the ATA Board of Directors as a Member at Large, is Clinical Director of the Division of Endocrinology at Beth Israel Deaconess Medical Center in Boston. He received his medical degree from University of Graz, in Graz, Austria. He completed intern and resident training in Internal Medicine at New Britain General Hospital in New Britain, Conn. He completed fellowship training in endocrinology and metabolism at Walter Reed Army Medical Center in Washington, D.C.
Dr. Sherman, newly appointed to the ATA Board of Directors as a Practicing Clinician, is an endocrinologist in Denver, Colorado. The major focus of her practice is thyroid disorders and thyroid cancer. She attended college and medical school at the University of North Carolina, Chapel Hill.
About the ATA Annual Meeting
The 82nd Annual Meeting of the American Thyroid Association is held Sept. 19-23, in Québec City, Québec, Canada. This four-day creative and innovative scientific program, chaired by Elizabeth Pearce, MD, Boston Medical Center, and Douglas Forrest, PhD, National Institute of Diabetes and Digestive and Kidney Diseases, carefully balances clinical and basic science sessions on the latest advances in thyroidology. The ATA meeting is designed to offer continuing education for endocrinologists, internists, surgeons, basic scientists, nuclear medicine scientists, pathologists, endocrine fellows and nurses, physician assistants and other health care professionals. Visit www.thyroid.org for more information.
About the ATA
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international individual membership organization with over 1,600 members from 43 countries around the world. Celebrating its 89th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, THYROID, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs through www.thyroid.org; and the development of guidelines for clinical management of thyroid disease. Visit www.thyroid.org for more information.
# # #